PubRank

Disulfide-containing parenteral delivery systems and their redox-biological fate.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 24952369)

Published in J Control Release on June 18, 2014

Authors

Lorine Brülisauer1, Marc A Gauthier2, Jean-Christophe Leroux3

Author Affiliations

1: Swiss Federal Institute of Technology Zurich (ETHZ), Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Vladimir-Prelog-Weg 1-5/10, 8093 Zurich, Switzerland.
2: Institut National de la Recherche Scientifique (INRS), EMT Research Center, 1650 boul. Lionel-Boulet, Varennes J3X 1S2, Canada.
3: Swiss Federal Institute of Technology Zurich (ETHZ), Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Vladimir-Prelog-Weg 1-5/10, 8093 Zurich, Switzerland. Electronic address: jleroux@ethz.ch.

Articles citing this ↘

Linker stability influences the anti-tumor activity of acetazolamide-drug conjugates for the therapy of renal cell carcinoma. J Control Release (2016) 0.77

Site-specific Isopeptide Bridge Tethering of Chimeric gp41 N-terminal Heptad Repeat Helical Trimers for the Treatment of HIV-1 Infection. Sci Rep (2016) 0.75

Linker Immolation Determines Cell Killing Activity of Disulfide-Linked Pyrrolobenzodiazepine Antibody-Drug Conjugates. ACS Med Chem Lett (2016) 0.75

Physico-Chemical Strategies to Enhance Stability and Drug Retention of Polymeric Micelles for Tumor-Targeted Drug Delivery. Macromol Biosci (2016) 0.75

A facile route to form self-carried redox-responsive vorinostat nanodrug for effective solid tumor therapy. Int J Nanomedicine (2016) 0.75

Decoupling stability and release in disulfide bonds with antibody-small molecule conjugates. Chem Sci (2016) 0.75